中国临床药理学杂志2017，Vol.33Issue(3)：265-266,270,3.DOI:10.13699/j.cnki.1001-6821.2017.03.021
《中国伏立康唑个体化用药指南》制订过程的探讨
Discussion of development of Chinese Practice Guideline for Individualized Medication of Voriconazole
摘要
Abstract
Collection and rating of evidence,survey of patients' preference and value and economic evaluation of the Practice Guideline for Therapeutic Drug Monitoring of Voriconazole have been finished.The Guideline Consensus Panel reached consensus of the recommendations by 3 rounds Delphi and Grading of Recommendations Assessment,Development and Evaluation grid method.Consensus of 38 recommendations was reached,with a consensus percentage of 50.7％.Twenty seven recommendations were finalized and approved by the Guideline Steering Committee.Draft recommendations were generated.关键词
伏立康唑/指南/推荐意见/德尔菲法Key words
voriconazole/guideline/recommendation/Delphi分类
医药卫生引用本文复制引用
陈恳,梁舒瑶,宋再伟,张相林,杜冠华,克晓燕,杨克虎,翟所迪..《中国伏立康唑个体化用药指南》制订过程的探讨[J].中国临床药理学杂志,2017,33(3):265-266,270,3.基金项目
中国伏立康唑个体化用药指南专项基金资助项目 （）
